Literature DB >> 20938001

Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity.

Anna Machalinska1, Monika Modrzejewska, Maciej Kotowski, Violetta Dziedziejko, Magda Kucia, Milosz Kawa, Krzysztof Safranow, Magdalena Baskiewicz-Masiuk, Anna Modrzejewska, Danuta Karczewicz, Jacek Rudnicki, Boguslaw Machalinski.   

Abstract

OBJECTIVE: To investigate the association among different circulating stem cell (SC) populations, the levels of selected growth factors and chemokines regulating SC migration in the peripheral blood, and the incidence of retinopathy of prematurity (ROP).
METHODS: We evaluated 88 participants in this study: 29 preterm infants with ROP, 29 preterm infants without ROP, and 30 healthy full-term infants. Peripheral blood samples collected 10 weeks after delivery were analyzed using flow cytometry, immunofluorescence, real-time reverse transcriptase-polymerase chain reaction, and enzyme-linked immunosorbent assay. The following cell populations were analyzed: (1) lin⁻CXCR4(+)CD45⁻ (enriched in very small embryonic-like SCs), (2) lin⁻CXCR4(+)CD45(+) (enriched in hematopoietic SCs), and (3) CD34(+)CD133(+)CD144(+) (early endothelial progenitor cells) [lin indicates lineage]. The concentrations of vascular endothelial growth factor, basic fibroblast growth factor, hepatocyte growth factor, and stromal cell-derived factor 1 were measured in the plasma.
RESULTS: The very small embryonic-like SCs and early endothelial progenitor cells expressing neural and endothelial markers were significantly increased in the preterm infants. The number of early endothelial progenitor cells in the peripheral blood was significantly greater in the preterm infants with ROP than in the preterm infants without ROP. An accompanying increase in the concentrations of vascular endothelial growth factor and hepatocyte growth factor was found in the peripheral blood of the preterm infants with ROP. No significant associations were found between hematopoietic SCs and ROP or prematurity.
CONCLUSIONS: The increased number of early endothelial progenitor cells along with elevated levels of vascular endothelial growth factor and hepatocyte growth factor in preterm infants with ROP suggest that circulating vasculogenic factors may play a role in the development and progression of ROP. The increased number of very small embryonic-like SCs in preterm infants suggests that the development of immature tissues and organs, including the retina, may require a contribution of circulating SCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938001     DOI: 10.1001/archophthalmol.2010.221

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  10 in total

1.  PPARα regulates mobilization and homing of endothelial progenitor cells through the HIF-1α/SDF-1 pathway.

Authors:  Zhongxiao Wang; Elizabeth Moran; Lexi Ding; Rui Cheng; Xun Xu; Jian-xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

2.  Mobilization of circulating progenitor cells following brain injury in premature neonates could be indicative of an endogenous repair process. A pilot study.

Authors:  N Efstathiou; V Soubasi; G Koliakos; G Kyriazis; D I Zafeiriou; A Slavakis; K Kantziou; T Pozotou; O Chatzizisi; V Drosou-Agakidou
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

3.  Effect of endothelial progenitor cells derived from human umbilical cord blood on oxygen-induced retinopathy in mice by intravitreal transplantation.

Authors:  Dan Wang; Bo Zhang; Hui Shi; Wei Yang; Ming-Chao Bi; Xiang-Fu Song; Chen Zhang; Jian-Hui Cheng; Ji-Long Hao; E Song
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

4.  Aberrant kinetics of bone marrow-derived endothelial progenitor cells in the murine oxygen-induced retinopathy model.

Authors:  Yoshihiro Nakagawa; Haruchika Masuda; Rie Ito; Michiru Kobori; Mika Wada; Tomoko Shizuno; Atsuko Sato; Takahiro Suzuki; Kenji Kawai; Takayuki Asahara
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-03       Impact factor: 4.799

Review 5.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

Review 6.  Retinopathy of prematurity: inflammation, choroidal degeneration, and novel promising therapeutic strategies.

Authors:  José Carlos Rivera; Mari Holm; Dordi Austeng; Tora Sund Morken; Tianwei Ellen Zhou; Alexandra Beaudry-Richard; Estefania Marin Sierra; Olaf Dammann; Sylvain Chemtob
Journal:  J Neuroinflammation       Date:  2017-08-22       Impact factor: 8.322

7.  Endothelial Progenitor Cells as Prognostic Markers of Preterm Birth-Associated Complications.

Authors:  Mariane Bertagnolli; Anne Monique Nuyt; Bernard Thébaud; Thuy Mai Luu
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

Review 8.  Vascular and Neuronal Protection in the Developing Retina: Potential Therapeutic Targets for Retinopathy of Prematurity.

Authors:  Jessica K W Tsang; Jin Liu; Amy C Y Lo
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

9.  Circulating hematopoietic stem cell count is a valuable predictor of prematurity complications in preterm newborns.

Authors:  Maciej Kotowski; Krzysztof Safranow; Miłosz P Kawa; Joanna Lewandowska; Patrycja Kłos; Violetta Dziedziejko; Edyta Paczkowska; Ryszard Czajka; Zbigniew Celewicz; Jacek Rudnicki; Bogusław Machaliński
Journal:  BMC Pediatr       Date:  2012-09-17       Impact factor: 2.125

10.  Comparative analysis of circulating endothelial progenitor cells in age-related macular degeneration patients using automated rare cell analysis (ARCA) and fluorescence activated cell sorting (FACS).

Authors:  Emil Anthony T Say; Alex Melamud; Denise Ann Esserman; Thomas J Povsic; Sai H Chavala
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.